Skip to main content

Advertisement

Log in

Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors—a longitudinal study of 106 patients

  • Clinical Article - Brain Tumors
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Reduced health-related quality of life (HRQoL) is a common complaint in patients suffering from pituitary tumors. Although successful tumor treatment has been reported to lead to an improvement in perceived HRQoL, the temporal gradient at which these improvements occur has not been fully addressed.

Methods

Using three validated health-related questionnaires (SF-36, SCL-90-R, QLS-H), we assessed HRQoL in 106 adult patients harboring pituitary tumors (mean age 48.0 ± 16.0 years) before as well as 3 and 12 months after initiation of treatment. The AcroQoL questionnaire was additionally applied in acromegalic patients.

Results

There was a significant improvement in all but one scale (role-physical) of the SF-36 questionnaire and all but two scales (interpersonal sensitivity, paranoid ideation) of the SCL-90-R, the QLS-H score and the AcroQoL subscales within 3 months after surgical treatment. The trend to amelioration continued at the 12 month re-assessment, but did not reach statistical significance. Linear regression analyses revealed that younger age and male gender favor a more distinct improvement of HRQoL after treatment.

Conclusions

HRQoL is considerably reduced before treatment for pituitary disease. Improvement is an early postoperative phenomenon and occurs within 3 months after treatment. Men and younger patients are more likely to improve within this time span.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AC:

Acromegaly

AcroQoL:

Acromegaly Quality of Life Questionnaire

CD:

Cushing’s disease

fT3:

Free tri-iodothyronine

fT4:

Free thyroxine

SF-36:

Short Form-36

SCL-90-R:

Symptom Checklist 90-Revised

HRQoL:

Health related quality of life

QLS-H:

Questions on Life Satisfaction-Hypopituitarism

References

  1. Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369–5376

    Article  PubMed  CAS  Google Scholar 

  2. Blum A, Maser E (2003) Enzymology and molecular biology of glucocorticoid metabolism in humans. Prog Nucleic Acid Res Mol Biol 75:173–216

    Article  PubMed  CAS  Google Scholar 

  3. Bullinger M, Kirchberger I (1998) SF-36. Fragebogen zum Gesundheitszustand. Handanweisung. Hogrefe, Göttingen

    Google Scholar 

  4. Burman P, Deijen JB (1998) Quality of life and cognitive function in patients with pituitary insufficiency. Psychother Psychosom 67:154–167, Review

    Article  PubMed  CAS  Google Scholar 

  5. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J (1991) The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68:860–866

    Article  PubMed  CAS  Google Scholar 

  6. Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:3364–3369

    Article  PubMed  CAS  Google Scholar 

  7. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912–919

    Article  PubMed  CAS  Google Scholar 

  8. Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV (1986) Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64:713–719

    Article  PubMed  CAS  Google Scholar 

  9. Feldkamp J, Santen R, Harms E, Aulich A, Mödder U, Scherbaum WA (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol [Oxf] 51:109–113

    Article  CAS  Google Scholar 

  10. Flitsch J, Spitzner S, Lüdecke DK (2000) Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 108:480–485

    Article  PubMed  CAS  Google Scholar 

  11. Franke G (1995) Die Symptom-Checkliste von Derogatis - Deutsche Version—[SCL-90-R]. Manual. Beltz Test GmbH, Göttingen

    Google Scholar 

  12. Furman K, Ezzat S (1998) Psychological features of acromegaly. Psychother Psychosom 67:147–153, Review

    Article  PubMed  CAS  Google Scholar 

  13. Herschbach P, Henrich G, Strasburger CJ, Feldmeier H, Marín F, Attanasio AM, Blum WF (2001) Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. Eur J Endocrinol 145:255–265

    Article  PubMed  CAS  Google Scholar 

  14. Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81–87

    Article  PubMed  Google Scholar 

  15. Kauppinen-Mäkelin R, Sane T, Sintonen H, Markkanen H, Välimäki MJ, Löyttyniemi E, Niskanen L, Reunanen A, Stenman UH (2006) Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91:3891–3896

    Article  PubMed  Google Scholar 

  16. Kelly WF, Kelly MJ, Faragher B (1996) A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol [Oxf] 45:715–720

    Article  CAS  Google Scholar 

  17. Korali Z, Wittchen HU, Pfister H, Höfler M, Oefelein W, Stalla GK (2003) Are patients with pituitary adenomas at an increased risk of mental disorders? Acta Psychiatr Scand 107:60–68

    Article  PubMed  CAS  Google Scholar 

  18. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447–453

    Article  PubMed  CAS  Google Scholar 

  19. Marazuela M, Astigarraga B, Vicente A, Estrada J, Cuerda C, García-Uría J, Lucas T (1994) Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Investig 17:703–707

    CAS  Google Scholar 

  20. McComb DJ, Ryan N, Horvath E, Kovacs K (1983) Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 107:488–491

    PubMed  CAS  Google Scholar 

  21. Nomikos P, Ladar C, Fahlbusch R, Buchfelder M (2004) Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas – a study on 721 patients. Acta Neurochir (Wien) 146:27–35, Erratum in: Acta Neurochir [Wien] 2004, 146:433

    Article  CAS  Google Scholar 

  22. Paisley AN, Trainer PJ (2003) Medical treatment in acromegaly. Curr Opin Pharmacol 3:672–677

    Article  PubMed  CAS  Google Scholar 

  23. Pantanetti P, Sonino N, Arnaldi G, Boscaro M (2002) Self image and quality of life in acromegaly. Pituitary 5:17–19, Review

    Article  PubMed  CAS  Google Scholar 

  24. Rosilio M, Blum WF, Edwards DJ, Shavrikova EP, Valle D, Lamberts SW, Erfurth EM, Webb SM, Ross RJ, Chihara K, Henrich G, Herschbach P, Attanasio AF (2004) Long-term improvement of quality of life during growth hormone [GH] replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism [QLS-H]. J Clin Endocrinol Metab 89:1684–1693

    Article  PubMed  CAS  Google Scholar 

  25. Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life [QOL] in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337–3341

    Article  PubMed  CAS  Google Scholar 

  26. Sardella C, Lombardi M, Rossi G, Cosci C, Brogioni S, Scattina I, Webb SM, Gasperi M, Martino E, Bogazzi F (2010) Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J Endocrinol Investig 33:20–25

    CAS  Google Scholar 

  27. van Aken MO, Lamberts SW (2005) Diagnosis and treatment of hypopituitarism: an update. Pituitary 8:183–191, Review

    Article  PubMed  Google Scholar 

  28. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short form health survey [SF-36]. Conceptual framework and item selection. Med Care 30:473–474

    Article  PubMed  Google Scholar 

  29. Webb SM, Badia X (2007) Quality of life in growth hormone deficiency and acromegaly. Endocrinol Metab Clin North Am 36:221–232, Review

    Article  PubMed  CAS  Google Scholar 

  30. Webb SM, Badia X, Surinach NL, Spanish AcroQoL Study Group (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155:269–277

    Article  PubMed  CAS  Google Scholar 

  31. Webb SM (2006) Quality of life in acromegaly. Neuroendocrinology 83:224–229

    Article  PubMed  CAS  Google Scholar 

  32. Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly Quality of Life Questionnaire [ACROQOL] a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol [Oxf] 57:251–258

    Article  CAS  Google Scholar 

  33. Wichers-Rother M, Hoven S, Kristof RA, Bliesener N, Stoffel-Wagner B (2004) Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp Clin Endocrinol Diabetes 112:323–327

    Article  PubMed  CAS  Google Scholar 

  34. Yanovski JA, Cutler GB Jr (1994) Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin N Am 23:487–509, Review

    CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tsambika Psaras.

Additional information

Comment

Well-being in pituitary surgery patients is a very interesting area. This nice study looks at outcomes in well being at time of surgery, at three months, and at 12 months from surgery. As expected, most improve significantly to three months except Cushing's patients (who will still be feeling unwell) and not much more until the 12-month review (which was not significant, although I would guess this was sample-size related).

The good thing is that most of our patients improve what ever!

Michael Powell

London, UK

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milian, M., Honegger, J., Gerlach, C. et al. Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors—a longitudinal study of 106 patients. Acta Neurochir 155, 1637–1645 (2013). https://doi.org/10.1007/s00701-013-1809-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-013-1809-7

Keywords

Navigation